José Pablo Miramontes González. Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies. // American Journal of Cardiovascular Drugs. – 2026. – DOI: 10.1007/s40256-026-00825-5. – URL: https://doi.org/10.1007/s40256-026-00825-5
José Pablo Miramontes González (2026). Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies. American Journal of Cardiovascular Drugs. https://doi.org/10.1007/s40256-026-00825-5
José Pablo Miramontes González. “Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies.” American Journal of Cardiovascular Drugs, 2026. doi:10.1007/s40256-026-00825-5.
@article{Gonzlez2026,
title = {Lipoprotein(a): Cardiovascular Risk and Emerging Targeted Therapies},
author = {González, José Pablo Miramontes},
journal = {American Journal of Cardiovascular Drugs},
year = {2026},
doi = {10.1007/s40256-026-00825-5},
url = {https://doi.org/10.1007/s40256-026-00825-5}
}